(1)
Jfri, A.; Meltzer, R.; Guggina, L. Runner Up: Incidence of Cutaneous Adverse Events With PI3K-Akt-MTOR Pathway Inhibitors: A Systematic Review and Network Meta-Analysis. J of Skin 2022, 6, s39.